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Background: Cardiac resynchronization therapy-defibrillator [CRT-D] implantation reduces the risk of ventricular arrhythmias in patients with left 
ventricular [LV] reverse remodelling. Some patients show dramatic improvement of LV ejection fraction [LVEF] due to LV reverse remodelling, hereby 
they outgrow eligibility for ICD. Data on device therapy of these super responders is scarce.
methods: All patients who underwent CRT-D implantation at Leiden University Medical Center are included. Patients are divided in subgroups 
according reduction in LV end-systolic volume [LVESV], 6 months after implantation. Subgroups are: responders (decreased LVESV 15-30%) and 
super responders (decreased LVESV >30%), remaining patients were excluded. During follow-up ICD therapy is registered.
results: During a median follow up of 48±41 months, 522 patients were followed (292 responders, 230 super responders). In 138 (47%) 
responders and 131 (57%) super responders LVEF was ≥35% after 6 months. The 5 year cumulative incidence of appropriate therapy is 32% (95% 
25-38) in responders and 25% (95% 17-33) in super responders (adjusted P=0.04). The 5 year cumulative incidence of appropriate shock is 18% 
(95% 13-24) and 11% (95% 6-17) in responders and super responders (adjusted P=0.06).
conclusions: CRT-D super responders receive significantly less appropriate ICD therapy compared to responders. However, 25% of super 
responders are treated for a potentially life threatening arrhythmia during follow up.
 
